Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 301-310 of 410 for multiple

Edit search filters
  1. A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Synucleinopathies

    Rochester, MN

  3. Longterm Follow-up of Subjects Treated With bb2121

    Rochester, MN

  4. Appointment Companion Tool

    Rochester, MN

  5. A Study to Assess Financial Burden and Its Impact on Quality of Life in Patients with Plasma Cell Disorders

    Rochester, MN

  6. Study Using Clofazimine to Treat Patients with Non-Tuberculous Mycobacterial Infections

    Scottsdale/Phoenix, AZ

  7. Stereotactic Body Radiation Therapy in Treating Patients with Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

    Rochester, MN

  8. A Study to Evaluate Lamprene (Clofazimine) to Treat Non-Tuberculous Mycobacterial (NTM) Infections

    Jacksonville, FL

  9. Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

    Rochester, MN

  10. Myeloma Referral Study (Race, Ethnicity, and Familial Etiologic Relationship, Risk Association, and Linkage Study)

    Rochester, MN

.

Mayo Clinic Footer